In summary, this pooled analysis of two large-scale RCTs in treatment-naïve advanced GC, CheckMate 649 and ORIENT-16, demonstrated that the efficacy of PD-1 blockade plus chemotherapy versus chemotherapy alone significantly attenuated in the CPS<5 subgroup than in the CPS≥5 subgroup. This evidence concerns the gene PDCD1 and gastric cancer.